AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10711985 — intervention group
Group type: EXPERIMENTAL
Intervention: Limb girdle muscular dystrophies
Number of subjects: 0
Study 10711985 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal myopathies
Number of subjects: 0
Study 10711985 — intervention group
Group type: EXPERIMENTAL
Intervention: Congenital muscular dystrophies
Number of subjects: 0
Study 10711985 — intervention group
Group type: EXPERIMENTAL
Intervention: Fukuyama congenital muscular dystrophy
Number of subjects: 0
Study 7791594 — intervention group
Group type: EXPERIMENTAL
Intervention: Exerstriders (E)
Number of subjects: 20
Study 7791594 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 20
Study 1646240 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril sodium (SQ 28,555) 10 to 640 mg once daily for 3 days
Number of subjects: 73
Study 1646240 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril sodium (SQ 28,555) 80 mg bid and 160 mg bid for 2 weeks
Number of subjects: 73
Study 1646240 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril sodium (SQ 28,555)
Number of subjects: 73
Study 6274372 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate combined with antacid
Number of subjects: 0
Study 6274372 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine combined with antacid
Number of subjects: 0
Study 6274372 — intervention group
Group type: COMPARATOR
Intervention: Saline combined with antacid
Number of subjects: 0
Study 30902761 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative surgery (27 cases)
Number of subjects: 60
Study 30902761 — intervention group
Group type: COMPARATOR
Intervention: Radical surgery (33 cases)
Number of subjects: 60
Study 30902761 — intervention group
Group type: EXPERIMENTAL
Intervention: KESS scores < 10 (reference)
Number of subjects: 60
Study 30902761 — intervention group
Group type: EXPERIMENTAL
Intervention: KESS scores between 10 and 17
Number of subjects: 60
Study 30902761 — intervention group
Group type: EXPERIMENTAL
Intervention: KESS scores > 17
Number of subjects: 60
Study 30902761 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall gastrointestinal, quality of life and urinary scores after surgery
Number of subjects: 60
Study 29912399 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime/avibactam
Number of subjects: 1146
Study 29912399 — intervention group
Group type: COMPARATOR
Intervention: Comparator (predominantly carbapenem)
Number of subjects: 1146
Study 26670162 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for gestational diabetes mellitus in primary care
Number of subjects: 0
Study 26670162 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for gestational diabetes mellitus in secondary care
Number of subjects: 0
Study 26670162 — intervention group
Group type: COMPARATOR
Intervention: No screening
Number of subjects: 0
Study 25369243 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine 1.2 mg/kg/day
Number of subjects: 97
Study 25369243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 22703757 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide Autogel 90 mg
Number of subjects: 148
Study 22703757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 20590389 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferguson operation with RF scalpel (group A)
Number of subjects: 28
Study 20590389 — intervention group
Group type: COMPARATOR
Intervention: Traditional diathermy (group B)
Number of subjects: 28
Study 18343939 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirulina
Number of subjects: 0
Study 18343939 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15849873 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) with weak complex waveform fields
Number of subjects: 89
Study 15849873 — intervention group
Group type: COMPARATOR
Intervention: Sham-field control group
Number of subjects: 89
Study 12823907 — intervention group
Group type: EXPERIMENTAL
Intervention: Diskus inhaler
Number of subjects: 0
Study 12823907 — intervention group
Group type: EXPERIMENTAL
Intervention: Turbuhaler
Number of subjects: 0
Study 12823907 — intervention group
Group type: COMPARATOR
Intervention: pMDI
Number of subjects: 0
Study 12823907 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry powder inhalers (DPIs)
Number of subjects: 0
Study 10393682 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganciclovir
Number of subjects: 149
Study 10393682 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 10393682 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganciclovir (no calcium blockers)
Number of subjects: 149
Study 10393682 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no calcium blockers)
Number of subjects: 149
Study 10393682 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganciclovir (with calcium blockers)
Number of subjects: 149
Study 10393682 — intervention group
Group type: COMPARATOR
Intervention: Placebo (with calcium blockers)
Number of subjects: 149
Study 8707991 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural self-management plus positive reinforcement
Number of subjects: 0
Study 8707991 — intervention group
Group type: COMPARATOR
Intervention: Basic oral hygiene instructions
Number of subjects: 0
Study 8707991 — intervention group
Group type: COMPARATOR
Intervention: Performance feedback
Number of subjects: 0
Study 8707991 — intervention group
Group type: COMPARATOR
Intervention: Behavioural self-management
Number of subjects: 0
Study 8707991 — intervention group
Group type: COMPARATOR
Intervention: Positive reinforcement
Number of subjects: 0
Study 1906164 — intervention group
Group type: EXPERIMENTAL
Intervention: Early discharge care model
Number of subjects: 0
Study 1906164 — intervention group
Group type: EXPERIMENTAL
Intervention: Institutional benefits
Number of subjects: 0
Study 6663640 — intervention group
Group type: EXPERIMENTAL
Intervention: Two therapists, long-term
Number of subjects: 0
Study 6663640 — intervention group
Group type: EXPERIMENTAL
Intervention: One therapist, long-term
Number of subjects: 0
Study 6663640 — intervention group
Group type: EXPERIMENTAL
Intervention: Two therapists, intensive
Number of subjects: 0
Study 6663640 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term therapy
Number of subjects: 0
Study 6663640 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy
Number of subjects: 0
Study 31415660 — intervention group
Group type: EXPERIMENTAL
Intervention: Complimentary counseling and educational support regarding EDOs
Number of subjects: 1053
Study 31415660 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control arm)
Number of subjects: 1053
Study 25679310 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation therapy combined with two cycles of concomitant cisplatin
Number of subjects: 224
Study 25679310 — intervention group
Group type: COMPARATOR
Intervention: Hyperfractionated radiation therapy alone
Number of subjects: 224
Study 24019259 — intervention group
Group type: EXPERIMENTAL
Intervention: KB001 10 mg/kg
Number of subjects: 27
Study 24019259 — intervention group
Group type: EXPERIMENTAL
Intervention: KB001 3 mg/kg
Number of subjects: 27
Study 24019259 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 23102241 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication therapy (group A, n = 261)
Number of subjects: 521
Study 23102241 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group B, n = 260)
Number of subjects: 521
Study 23102241 — intervention group
Group type: COMPARATOR
Intervention: Non-H. pylori-eradicated cases (group B, n = 260)
Number of subjects: 521
Study 19573883 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (12 weeks, 5 days/week, 1 hour/day, 65% peak oxygen consumption)
Number of subjects: 10
Study 19573883 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 10
Study 17907485 — intervention group
Group type: EXPERIMENTAL
Intervention: Silane application with Single Bond adhesive
Number of subjects: 0
Study 17907485 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrofluoric acid-etching and silane application with Clearfil Photo Bond adhesive
Number of subjects: 0
Study 17907485 — intervention group
Group type: EXPERIMENTAL
Intervention: No treatment with Clearfil New Bond adhesive
Number of subjects: 0
Study 17907485 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 15050375 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid stream stimulation paradigm (RSS) with a high rate of presentation (250 ms) and a minimum of two background stimuli preceding each word.
Number of subjects: 0
Study 15050375 — intervention group
Group type: COMPARATOR
Intervention: Standard paradigms such as rapid serial visual presentation without interspersed background stimuli.
Number of subjects: 0
Study 10753983 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (2 mg)
Number of subjects: 61
Study 10753983 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 1 mg warfarin plus 300 mg aspirin
Number of subjects: 61
Study 10753983 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 2 mg warfarin plus 300 mg aspirin
Number of subjects: 61
Study 10753983 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted-dose warfarin (INR 2.0 to 3.0)
Number of subjects: 61
Study 10753983 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects in sinus rhythm
Number of subjects: 61
Study 8830977 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg dextromethorphan hydrobromide
Number of subjects: 7
Study 8830977 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenotyping using metabolic ratios
Number of subjects: 7
Study 1309476 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat bran
Number of subjects: 6
Study 1309476 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat fiber
Number of subjects: 6
Study 1309476 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat germ
Number of subjects: 6
Study 1309476 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice bran
Number of subjects: 6
Study 1309476 — intervention group
Group type: COMPARATOR
Intervention: Control (low-fiber test meal)
Number of subjects: 6
Study 6729671 — intervention group
Group type: EXPERIMENTAL
Intervention: Herniography pre- and postoperatively
Number of subjects: 0
Study 6729671 — intervention group
Group type: COMPARATOR
Intervention: Herniectomy without ligation of the sac
Number of subjects: 0
Study 30813694 — intervention group
Group type: EXPERIMENTAL
Intervention: Butylphthalide treatment group
Number of subjects: 120
Study 30813694 — intervention group
Group type: COMPARATOR
Intervention: Non-invasive ventilation control group
Number of subjects: 120
Study 30813694 — intervention group
Group type: EXPERIMENTAL
Intervention: Butylphthalide combined with non-invasive ventilation group
Number of subjects: 120
Study 29474441 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive Writing Intervention (EWI)
Number of subjects: 507
Study 29474441 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive Writing Intervention (EWI) - writing about their own cancer
Number of subjects: 507
Study 29474441 — intervention group
Group type: COMPARATOR
Intervention: Control - non-disclosing topic
Number of subjects: 507
Study 26577208 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological exertion above the second lactate threshold (LT2)
Number of subjects: 28
Study 26577208 — intervention group
Group type: COMPARATOR
Intervention: Light and moderate-intensity exercise below the LT2
Number of subjects: 28
Study 22514730 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadoxine‐pyrimethamine (SP) administered early (4 months of gestation)
Number of subjects: 1439
Study 22514730 — intervention group
Group type: COMPARATOR
Intervention: Sulfadoxine‐pyrimethamine (SP) administered late (6-7 months of gestation)
Number of subjects: 1439
Study 20573791 — intervention group
Group type: EXPERIMENTAL
Intervention: (6S)-[(13)C(5)]5-CH(3)-H(4) folate from whole-meal bread
Number of subjects: 8
Study 20573791 — intervention group
Group type: COMPARATOR
Intervention: [(13)C(5)]folic acid from fortified bread
Number of subjects: 8
Study 20573791 — intervention group
Group type: COMPARATOR
Intervention: [(13)C(5)]folic acid from fortified breakfast meal
Number of subjects: 8
Study 18405788 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin 25 mg
Number of subjects: 56
Study 18405788 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin 100 mg
Number of subjects: 56
Study 18405788 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin 400 mg
Number of subjects: 56
Study 18405788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 15888152 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 3 mg kg(‐1)
Number of subjects: 249
Study 15888152 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg kg(‐1)
Number of subjects: 249
Study 15888152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249
Study 12766522 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator (ICD) therapy
Number of subjects: 0
Study 12766522 — intervention group
Group type: COMPARATOR
Intervention: Antiarrhythmic drug therapy (e.g., amiodarone)
Number of subjects: 0
Study 12766522 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients experiencing shocks from ICDs
Number of subjects: 0
Study 12766522 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple shocks from ICDs
Number of subjects: 0
Study 10667832 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexibuprofen 400 mg t.i.d.
Number of subjects: 178
Study 10667832 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexibuprofen 200 mg t.i.d.
Number of subjects: 178
Study 10667832 — intervention group
Group type: COMPARATOR
Intervention: Racemic ibuprofen 800 mg t.i.d.
Number of subjects: 178
Study 9006224 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centred consulting training programme
Number of subjects: 55
Study 9006224 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation of diabetes review consultations before and after training
Number of subjects: 55
Study 1297554 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical collar therapy
Number of subjects: 32
Study 1297554 — intervention group
Group type: COMPARATOR
Intervention: Natural course (control)
Number of subjects: 32
Study 3906995 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorbutin
Number of subjects: 186
Study 3906995 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 186
Study 3906995 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine (large and mean doses)
Number of subjects: 186
Study 3906995 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 186
Study 3906995 — intervention group
Group type: COMPARATOR
Intervention: Nonsteroidal antiinflammatory drugs (NAID)
Number of subjects: 186
Study 30578651 — intervention group
Group type: EXPERIMENTAL
Intervention: normoxic helium‐oxygen (HEL)
Number of subjects: 18
Study 30578651 — intervention group
Group type: EXPERIMENTAL
Intervention: inspiratory resistance (RES) of ∼5 cmH2O L−1 s−1
Number of subjects: 18
Study 30578651 — intervention group
Group type: COMPARATOR
Intervention: ambient air (CON)
Number of subjects: 18
Study 30578651 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall dyspnoea intensity
Number of subjects: 18
Study 29622281 — intervention group
Group type: EXPERIMENTAL
Intervention: Education group (self-management education)
Number of subjects: 118
Study 26851152 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Habits, Healthy Girls-Brazil program
Number of subjects: 253
Study 24812899 — intervention group
Group type: EXPERIMENTAL
Intervention: Ningdong Granule (NG), one dose daily for 3 months, dissolved in boiled water, taken in two portions in the morning and evening.
Number of subjects: 90
Study 24812899 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with NG and Tiapride, equal doses for 3 months.
Number of subjects: 90
Study 24812899 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiapride Tablet, 50-100 mg twice daily for 3 months, max dosage 300 mg per day.
Number of subjects: 90
Study 24812899 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group, no intervention.
Number of subjects: 90
Study 23044291 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent
Number of subjects: 122
Study 23044291 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus-eluting stent
Number of subjects: 122
Study 19680706 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS (left prefrontal 10 Hz)
Number of subjects: 30
Study 19680706 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 30
Study 17932094 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete ST resolution (> or =50%)
Number of subjects: 4565
Study 17932094 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior myocardial infarction (MI) in the highest quartile of SigmaSTD with complete ST resolution
Number of subjects: 4565
Study 17932094 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior myocardial infarction (MI) in the highest quartile of SigmaSTD with incomplete ST resolution
Number of subjects: 4565
Study 17932094 — intervention group
Group type: EXPERIMENTAL
Intervention: Inferior myocardial infarction (MI) with incomplete ST resolution
Number of subjects: 4565
Study 18204271 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro (LPI)
Number of subjects: 103
Study 18204271 — intervention group
Group type: COMPARATOR
Intervention: Regular insulin (RGI)
Number of subjects: 103
Study 15125006 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral bone densitometry (PD) system (GE/Lunar PIXI)
Number of subjects: 24
Study 15125006 — intervention group
Group type: COMPARATOR
Intervention: Computed radiography (CR) system (Fuji)
Number of subjects: 24
Study 11379380 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous estradiol 50 micrograms/24 h with vaginal progesterone gel 8 mg every 2nd day
Number of subjects: 12
Study 11379380 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous estradiol 50 micrograms/24 h with medroxyprogesterone acetate 5 mg/day orally during 12 days per month
Number of subjects: 12
Study 9404445 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone treatment (250 mg testosterone enanthate/month for four months)
Number of subjects: 19
Study 9404445 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched pubertal controls)
Number of subjects: 19
Study 8321561 — intervention group
Group type: EXPERIMENTAL
Intervention: Constavac autoreinfusion device
Number of subjects: 91
Study 8321561 — intervention group
Group type: COMPARATOR
Intervention: Hemovac standard suction device
Number of subjects: 91
Study 3463572 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% folate mouthwash
Number of subjects: 20
Study 3463572 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 20
Study 11451839 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human deoxyribonuclease I (rhDNase)
Number of subjects: 75
Study 11451839 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 75
Study 31147085 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine
Number of subjects: 654
Study 31147085 — intervention group
Group type: COMPARATOR
Intervention: Standard postpartum care (Control)
Number of subjects: 654
Study 30007535 — intervention group
Group type: EXPERIMENTAL
Intervention: PACE (Patient Centered Weight Loss Program) starting ≤6 weeks before surgery
Number of subjects: 16
Study 30007535 — intervention group
Group type: COMPARATOR
Intervention: Delayed PACE (Patient Centered Weight Loss Program) starting at 12 weeks post-op
Number of subjects: 16
Study 30007535 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PACE and Delayed PACE)
Number of subjects: 16
Study 27659544 — intervention group
Group type: EXPERIMENTAL
Intervention: UT‐DSAEK
Number of subjects: 66
Study 27659544 — intervention group
Group type: COMPARATOR
Intervention: DSAEK
Number of subjects: 66
Study 25049329 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) followed by chemoradiotherapy (CRT) - docetaxel 75 mg/m² on day 1, cisplatin 75 mg/m² on day 1, fluorouracil 750 mg/m² on days 1 to 5, followed by CRT (docetaxel, fluorouracil, hydroxyurea plus radiotherapy 0.15 Gy twice per day every other week)
Number of subjects: 285
Study 25049329 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiotherapy (CRT) alone - docetaxel, fluorouracil, and hydroxyurea plus radiotherapy 0.15 Gy twice per day every other week
Number of subjects: 285
Study 22215218 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra early cranioplasty (reimplantation of the patient's own skull flap)
Number of subjects: 242
Study 22215218 — intervention group
Group type: COMPARATOR
Intervention: Early cranioplasty (7-12 weeks)
Number of subjects: 242
Study 22215218 — intervention group
Group type: COMPARATOR
Intervention: Delayed cranioplasty (after 13 weeks)
Number of subjects: 242
Study 20083373 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol (acetaminophen) 4 g daily
Number of subjects: 31
Study 20083373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 19226897 — intervention group
Group type: EXPERIMENTAL
Intervention: Visceral differentiation-based acupuncture therapy
Number of subjects: 70
Study 19226897 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture therapy
Number of subjects: 70
Study 16028648 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained pressure-controlled inflation (15 s)
Number of subjects: 61
Study 16028648 — intervention group
Group type: COMPARATOR
Intervention: Intermittent mandatory ventilation (rate 60 min(‐1))
Number of subjects: 61
Study 16028648 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 61
Study 11987872 — intervention group
Group type: EXPERIMENTAL
Intervention: Original training stimulus exposure
Number of subjects: 85
Study 11987872 — intervention group
Group type: COMPARATOR
Intervention: Different mobile or context exposure
Number of subjects: 85
Study 11987872 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing after increasing delays with original stimulus, exposed stimulus, or novel stimulus
Number of subjects: 85
Study 10577566 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 362